|
US5250528A
(en)
*
|
1989-08-02 |
1993-10-05 |
Fujisawa Pharmaceutical Co., Ltd. |
New aminopiperazine derivatives
|
|
GB8917687D0
(en)
*
|
1989-08-02 |
1989-09-20 |
Fujisawa Pharmaceutical Co |
Aminopiperazine derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
|
|
GB2236751B
(en)
|
1989-10-14 |
1993-04-28 |
Wyeth John & Brother Ltd |
Heterocyclic compounds
|
|
EP0968201A2
(en)
*
|
1997-02-17 |
2000-01-05 |
Fujisawa Pharmaceutical Co., Ltd. |
New aminopiperazine derivatives
|
|
ID24525A
(id)
*
|
1997-07-31 |
2000-07-20 |
Hoffmann La Roche |
Turunan-turunan hidroksikumaranon tersubstitusi-0 sebagai zat anti tumor dan zat antimetastatik
|
|
US20040133286A1
(en)
|
2001-01-10 |
2004-07-08 |
Takehiko Futatsugi |
Automatic control system
|
|
US20050197350A1
(en)
|
2003-03-31 |
2005-09-08 |
Taisho Pharmaceutical Co., Ltd. |
Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
|
|
CA2881078C
(en)
|
2004-06-24 |
2018-10-02 |
Vertex Pharmaceuticals Incorporated |
Modulators of atp-binding cassette transporters
|
|
JP4868731B2
(ja)
|
2004-11-17 |
2012-02-01 |
独立行政法人理化学研究所 |
哺乳動物培養細胞由来の無細胞タンパク質合成システム
|
|
FR2918984B1
(fr)
*
|
2007-07-16 |
2012-09-21 |
Sanofi Aventis |
Derives de pyrazole 3,5-carboxylates,leur preparation et leur application en therapeutique
|
|
WO2009151800A1
(en)
|
2008-05-07 |
2009-12-17 |
Merck & Co., Inc. |
Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment
|
|
US8273900B2
(en)
|
2008-08-07 |
2012-09-25 |
Novartis Ag |
Organic compounds
|
|
EP2531490B1
(en)
|
2010-02-02 |
2014-10-15 |
Novartis AG |
Cyclohexyl amide derivatives as crf receptor antagonists
|
|
WO2014072061A1
(en)
|
2012-11-09 |
2014-05-15 |
Biontech Ag |
Method for cellular rna expression
|
|
WO2014144952A2
(en)
|
2013-03-15 |
2014-09-18 |
Peter Walter |
Modulators of the eif2alpha pathway
|
|
TW201808888A
(zh)
|
2016-05-05 |
2018-03-16 |
嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
TWI920577B
(zh)
|
2016-05-05 |
2026-04-01 |
美商嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
TW201808903A
(zh)
|
2016-05-05 |
2018-03-16 |
嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
TW201808914A
(zh)
|
2016-05-05 |
2018-03-16 |
嘉來克生命科學有限責任公司 |
整合應激途徑之調節劑
|
|
CA3026983A1
(en)
*
|
2016-06-08 |
2017-12-14 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical compounds
|
|
RU2018145734A
(ru)
*
|
2016-06-08 |
2020-07-14 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Химические соединения в качестве ингибиторов atf4 пути
|
|
CN110730777A
(zh)
|
2017-06-07 |
2020-01-24 |
葛兰素史密斯克莱知识产权发展有限公司 |
作为atf4通路抑制剂的化学化合物
|
|
EP3649108A1
(en)
|
2017-07-03 |
2020-05-13 |
GlaxoSmithKline Intellectual Property Development Limited |
2-(4-chlorophenoxy)-n-((1 -(2-(4-chlorophenoxy)ethynazetidin-3-yl)methyl)acetamide derivatives and related compounds as atf4 inhibitors for treating cancer and other diseases
|
|
WO2019008506A1
(en)
|
2017-07-03 |
2019-01-10 |
Glaxosmithkline Intellectual Property Development Limited |
N- (3- (2- (4-CHLOROPHENOXY) ACETAMIDO) BICYCLO [1.1.1] PENTAN-1-YL) -2-CYCLOBUTANE-1-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ATF4 INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER DISEASES
|
|
IL301709B2
(en)
|
2017-08-09 |
2025-07-01 |
Denali Therapeutics Inc |
Compounds, compositions and methods
|
|
TW201920129A
(zh)
|
2017-09-01 |
2019-06-01 |
美商戴納立製藥公司 |
化合物、組合物及方法
|
|
BR112020008825A2
(pt)
|
2017-11-02 |
2020-10-20 |
Calico Life Sciences Llc |
moduladores da via de estresse integrada
|
|
UY37956A
(es)
|
2017-11-02 |
2019-05-31 |
Abbvie Inc |
Moduladores de la vía de estrés integrada
|
|
UY37958A
(es)
|
2017-11-02 |
2019-05-31 |
Abbvie Inc |
Moduladores de la vía de estrés integrada
|
|
SG11202004009TA
(en)
|
2017-11-02 |
2020-05-28 |
Calico Life Sciences Llc |
Modulators of the integrated stress pathway
|
|
UY37957A
(es)
|
2017-11-02 |
2019-05-31 |
Abbvie Inc |
Moduladores de la vía de estrés integrada
|
|
JP2021501785A
(ja)
|
2017-11-02 |
2021-01-21 |
カリコ ライフ サイエンシーズ エルエルシー |
統合的ストレス経路の調節剤
|
|
MX2020004537A
(es)
|
2017-11-02 |
2020-10-05 |
Calico Life Sciences Llc |
Moduladores de la vía integrada del estrés.
|
|
EP3704125B1
(en)
|
2017-11-02 |
2026-03-11 |
Calico Life Sciences LLC |
Modulators of the integrated stress pathway
|
|
MX2020004538A
(es)
|
2017-11-02 |
2020-09-18 |
Calico Life Sciences Llc |
Moduladores de la vía de estrés integrada.
|
|
JP2021508336A
(ja)
|
2017-12-13 |
2021-03-04 |
プラクシス バイオテック エルエルシー |
統合的ストレス応答経路の阻害剤
|
|
WO2019183589A1
(en)
|
2018-03-23 |
2019-09-26 |
Denali Therapeutics Inc. |
Modulators of eukaryotic initiation factor 2
|
|
WO2019193541A1
(en)
|
2018-04-06 |
2019-10-10 |
Glaxosmithkline Intellectual Property Development Limited |
Bicyclic aromatic ring derivatives of formula (i) as atf4 inhibitors
|
|
WO2019193540A1
(en)
|
2018-04-06 |
2019-10-10 |
Glaxosmithkline Intellectual Property Development Limited |
Heteroaryl derivatives of formula (i) as atf4 inhibitors
|
|
JP2021529814A
(ja)
|
2018-07-09 |
2021-11-04 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
化学化合物
|
|
WO2020031107A1
(en)
|
2018-08-08 |
2020-02-13 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical compounds
|
|
TW202545902A
(zh)
|
2018-10-11 |
2025-12-01 |
美商嘉來克生命科學有限責任公司 |
整合應激路徑之前藥調節劑
|
|
CR20210426A
(es)
|
2019-02-13 |
2021-09-30 |
Denali Therapeutics Inc |
Compuestos, composiciones y métodos
|
|
EP3924341A4
(en)
|
2019-02-13 |
2022-11-02 |
Denali Therapeutics Inc. |
Compounds, compositions and methods
|
|
SG11202107871UA
(en)
|
2019-02-25 |
2021-08-30 |
Praxis Biotech LLC |
Inhibitors of integrated stress response pathway
|
|
US20220177456A1
(en)
|
2019-03-06 |
2022-06-09 |
Denali Therapeutics Inc. |
Compounds, compositions and methods
|
|
WO2020216766A1
(en)
|
2019-04-23 |
2020-10-29 |
Evotec International Gmbh |
Modulators of the integrated stress response pathway
|
|
MX2021012904A
(es)
|
2019-04-23 |
2022-01-18 |
Evotec Int Gmbh |
Moduladores de la via de respuesta al estres integrada.
|
|
AR118836A1
(es)
|
2019-04-30 |
2021-11-03 |
Calico Life Sciences Llc |
Moduladores de la vía de tensión integrada
|
|
PH12021552759A1
(en)
|
2019-04-30 |
2022-07-04 |
Abbvie Inc |
Substituted cycloalkyls as modulators of the integrated stress pathway
|
|
JP2022536663A
(ja)
|
2019-06-12 |
2022-08-18 |
プラクシス バイオテック エルエルシー |
統合的ストレス応答経路のモジュレーター
|
|
JP2022536901A
(ja)
|
2019-06-12 |
2022-08-22 |
プラクシス バイオテック エルエルシー |
統合的ストレス応答経路の阻害剤
|